X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CLINICAL DRUG INVESTIGATION

期刊標題檢索 CLIN DRUG INVES 最新評論: It has been 2 weeks (2024-01-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CLINICAL DRUG INVESTIGATION]您好,您是該頁面的第 18659 位訪客。

期刊簡介
期刊名稱CLINICAL DRUG INVESTIGATION CLINICAL DRUG INVESTIGATION
LetPub Score
5.2
50 ratings
Rate

Reputation
6.4

Influence
3.9

Speed
7.0

期刊簡稱CLIN DRUG INVEST
ISSN1173-2563
E-ISSN1179-1918
h-index53
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.900.6800.798
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q281 / 272

自引率 (2023-2024)3.40%自引率趨勢
掲載範囲
Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

-Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.
-Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

-Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

-Studies focusing on the application of drug delivery technology in healthcare.

-Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.
官方網站https://www.springer.com/40261
在線稿件提交https://www.editorialmanager.com/cdia/
開放訪問No
出版商Springer International Publishing
主題領域医学
出版國/地區NEW ZEALAND
發行頻率月刊
創刊年1989
每年文章數85每年文章數趨勢
黃金OA百分比44.96%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2147/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-2563%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CLINICAL DRUG INVESTIGATION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498338
    PHYTOMEDICINE340372
    LIFE SCIENCES285850
    International Journal of Pharmaceutics242444
    PHARMACOLOGICAL RESEARCH241359
    European Journal of Pharmacology204253
    BIOCHEMICAL PHARMACOLOGY202706
    JOURNAL OF NATURAL PRODUCTS196697
    BRITISH JOURNAL OF PHARMACOLOGY165151
    MOLECULAR PHARMACEUTICS162838
  •  

    CLINICAL DRUG INVESTIGATION CLINICAL DRUG INVESTIGATION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CLINICAL DRUG INVESTIGATION] 的評論撰寫評論
作者: Renata Richardson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-04 08:02:02 評論於
It has been 2 weeks
(0) 讚! | Renata Richardson

作者: Renata Richardson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-29 21:45:34 評論於
It has been nine days
(0) 讚! | Renata Richardson

作者: 书生念凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-10 12:27:20 評論於
How much is the ad space fee? Or do we need to pay for the ad space?
(0) 讚! | 书生念凡

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:51:51 評論於
Medicine, Scientific Reports, Plos One, Oncology Letter, Oncology Report, Cell Physiol Biochem, Biochemical and Biophysical Research, etc
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:19:26 評論於
Do not submit to newly emerging magazines with rapidly increasing impact factors; do not submit to journals with fewer publications; do not submit to journals from regions with less developed academia. Safe journals are those published by larger publishing groups or some high-impact factor magazines
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:04:28 評論於
Which journals are widely recognized as top-tier publications?
(0) 讚! | 陶宜三岁啦

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:42:22 評論於
What pitfalls should be avoided when selecting publications?
(0) 讚! | 破戒阳平

作者: 猫巷少女杉月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 08:40:14 評論於
Do you accept submission processing fees? Thank you!
(0) 讚! | 猫巷少女杉月

作者: 华清松雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-09-25 21:43:24 評論於
Editorial speed: 1.0 | Submission hit rate: 50.0
Experience sharing: I submitted my paper on July 19, 2016, and received major revisions on August 19. The revision period was originally one month, with over 60 review comments. However, the journal requested a submission within two weeks, so I had to rush to make revisions. I submitted the revised paper on the deadline of September 3, and fortunately it was accepted on September 8. Overall, the journal's efficiency is very high, and the opinions of the editors and reviewers are very fair and friendly. The attitude of the authors is also very important. My paper was about META of tumor drugs. Also, no page charges, no page charges!!!!!
(0) 讚! | 华清松雨

作者: 努力啊大凡霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-13 21:13:47 評論於
Why can't I find the submission link for this magazine?
(0) 讚! | 努力啊大凡霜

作者: 运峰酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-01-14 17:25:39 評論於
@wangwen414 How many days does it usually take for an Editor Assigned status? It's been eight days for me and there hasn't been any changes. Thanks
(0) 讚! | 运峰酱大魔王

作者: 西域嘉庆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-01-12 20:34:51 評論於
My first SCI paper in my medical career was accepted today, and it was a meta-analysis. Overall, I feel that the journal is very efficient. I submitted it on October 24, 2015, and it was accepted on January 12, 2016. There was a major revision in between, and the editor-in-chief was very attentive, directly marking any grammar corrections on the revised PDF
(0) 讚! | 西域嘉庆

作者: 运峰酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-01-12 18:20:11 評論於
@wangwen414 Hello, may I ask how long does it usually take for the magazine to assign an editor after submission? It's been 8 days since I submitted my article and the status is still "Editor Assigned". Why hasn't it changed yet? Thank you
(0) 讚! | 运峰酱大魔王

作者: 运峰酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-12-15 23:00:34 評論於
@jocelyn624 Hello, I have an article I would like to submit to the magazine. Could you please provide the submission link? Thank you
(0) 讚! | 运峰酱大魔王

作者: 博延公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-20 19:27:35 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Experience sharing: It should be a copyright-free journal with relatively high efficiency. It took a total of one month and ten days from submission to acceptance. The journal favors clinical trials and meta-analysis. For meta-analysis, it is most important to measure scores and race against time. If others publish first, it will be left behind. Therefore, as long as you can accept risks, you can try high-scoring journals. I cannot accept risks, so I submitted to this journal. Overall, it is very nice. During major revisions, the editor directly edited the grammar in the submitted PDF, which touched me. It is the first time I have seen such a sincere editor after submitting so many journals
(0) 讚! | 博延公子

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CLINICAL DRUG INVESTIGATION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*